SCHEMBL11926285

SCHEMBL11926285

Cc1[nH]c2ccc(NC(=O)c3cc(NCC(=O)N(C)CCO)nc(N4CCOCC4)n3)cc2c1C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.39
▸ GLA P06280 2/20 0.39
▸ KDM4E B2RXH2 3/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ HPGD P15428 2/20 0.39
▸ HSD17B10 Q99714 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ RAF1 P04049 10/20 0.38
▸ BRAF P15056 10/20 0.38
▸ LMNA P02545 1/20 0.37
▸ ALOX15 P16050 1/20 0.37
▸ NAPEPLD Q6IQ20 1/20 0.36
▸ PIK3CA P42336 2/20 0.36
▸ TP53 P04637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11926289 0.93 ALDH1A1 (0.47) ALDH1A1GLAKDM4EL3MBTL1HPGD
SCHEMBL11926294 0.92 PIK3CA (0.43) ALDH1A1GLAKDM4EL3MBTL1HPGD
SCHEMBL3116305 0.88 PIN1 (0.44) ALDH1A1GLAKDM4EL3MBTL1HPGD
SCHEMBL3100505 0.88 ALDH1A1 (0.52) ALDH1A1GLAKDM4EL3MBTL1RAF1
SCHEMBL11926280 0.87 PIK3CA (0.44) ALDH1A1GLAKDM4EL3MBTL1KMT2A
SCHEMBL11926287 0.87 ALDH1A1 (0.42) ALDH1A1GLAKDM4EL3MBTL1HPGD
SCHEMBL11926274 0.86 ALDH1A1 (0.43) ALDH1A1GLAKDM4EL3MBTL1HPGD
SCHEMBL3103694 0.86 PIK3CA (0.42) ALDH1A1GLAKDM4EL3MBTL1HPGD
SCHEMBL11926290 0.85 ALDH1A1 (0.43) ALDH1A1GLAKDM4EL3MBTL1HPGD
SCHEMBL11926288 0.85 KDM4E (0.42) ALDH1A1KDM4EL3MBTL1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8236795-B2 IL-12 modulatory compounds SYNTA PHARMACEUTICALS CORP. (US) 2012-08-07 — — US disclosed
US-8236795-B2 IL-12 modulatory compounds SYNTA PHARMACEUTICALS CORP. (US) 2012-08-07 — — US disclosed
US-20100256132-A1 IL-12 MODULATORY COMPOUNDS SYNTA PHARMACEUTICALS CORPORATION (US) 2010-10-07 — — US disclosed
US-20100256132-A1 IL-12 MODULATORY COMPOUNDS SYNTA PHARMACEUTICALS CORPORATION (US) 2010-10-07 — — US disclosed
US-7696202-B2 IL-12 modulatory compounds SYNTA PHARMACEUTICALS CORP. (US) 2010-04-13 — — US disclosed
US-7696202-B2 IL-12 modulatory compounds SYNTA PHARMACEUTICALS CORP. (US) 2010-04-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100256132-A1 IL-12 MODULATORY COMPOUNDS IL2, IL4, IFNG ALDH1A1 1381/4885GLA 1497/4885KDM4E 3666/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback